Tuesday, October 29, 2002 9:37:44 AM
IBCI Receives Patent Approval From Mexican Patent Office Which Broadens Worldwide Protection of Proprietary Technology
Tuesday October 29, 9:15 am ET
ATLANTA, Oct. 29 /PRNewswire-FirstCall/ -- International BioChemical Industries, Inc. (OTC Bulletin Board: IBCL - News) announces today that it has recently received from the Mexican Patent Office an approval extending IBCI's antimicrobial, securing the rights to a broader protection of its proprietary technology. This new patent approval helps to solidify IBCI's positioning in the Mexican markets, bringing achievement to the ongoing plans for international growth. Deirdre Baker, IBCI's General Manager, stated, "This new Patent approval contributes a great deal to our competitive advantage, creates new barriers to entry for our competition to participate in the antimicrobial and antibacterial industries, and further enhances and protects IBCI's intellectual property portfolio.
About BioShield Technologies, Inc./International BioChemical
Industries, Inc.:
International BioChemical Industries, Inc. is a Norcross, Georgia-based
emerging growth company focused in biotechnology and antimicrobial products.
Its core business is committed to the discovery, development, marketing and
sale of surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is a revolutionary alternative to conventional
sanitizers, disinfectants, bleaches, biocides or preservatives primarily
because it kills bacteria, including HIV, on contact and can remain active for
extended time periods. To date BioShield has received three U.S. patents and
eight EPA registrations, including the first U.S. germ killer and disinfectant
against Salmonella cholerasuis, Staphylococcus aureus and other
microorganisms. The company has developed several alliances in different
industries, such as healthcare, textiles and storm water.
Further information on IBCI and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling Deirdre Baker at 1-770-925-3653.
Safe Harbor/Forward-looking Statements: Statements in this news release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward- looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of IBCI the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. IBCI does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of IBCI.
The best weapon against "fear" is "facts"!!
Tuesday October 29, 9:15 am ET
ATLANTA, Oct. 29 /PRNewswire-FirstCall/ -- International BioChemical Industries, Inc. (OTC Bulletin Board: IBCL - News) announces today that it has recently received from the Mexican Patent Office an approval extending IBCI's antimicrobial, securing the rights to a broader protection of its proprietary technology. This new patent approval helps to solidify IBCI's positioning in the Mexican markets, bringing achievement to the ongoing plans for international growth. Deirdre Baker, IBCI's General Manager, stated, "This new Patent approval contributes a great deal to our competitive advantage, creates new barriers to entry for our competition to participate in the antimicrobial and antibacterial industries, and further enhances and protects IBCI's intellectual property portfolio.
About BioShield Technologies, Inc./International BioChemical
Industries, Inc.:
International BioChemical Industries, Inc. is a Norcross, Georgia-based
emerging growth company focused in biotechnology and antimicrobial products.
Its core business is committed to the discovery, development, marketing and
sale of surface-modifying antimicrobial and biostatic products. The company's
antimicrobial technology is a revolutionary alternative to conventional
sanitizers, disinfectants, bleaches, biocides or preservatives primarily
because it kills bacteria, including HIV, on contact and can remain active for
extended time periods. To date BioShield has received three U.S. patents and
eight EPA registrations, including the first U.S. germ killer and disinfectant
against Salmonella cholerasuis, Staphylococcus aureus and other
microorganisms. The company has developed several alliances in different
industries, such as healthcare, textiles and storm water.
Further information on IBCI and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling Deirdre Baker at 1-770-925-3653.
Safe Harbor/Forward-looking Statements: Statements in this news release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward- looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of IBCI the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. IBCI does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of IBCI.
The best weapon against "fear" is "facts"!!
The best weapon against "fear" is "facts"!!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
